A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
2024 Precision Medicine Tri-Conference March 26-28 | San Diego, CA Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in precision medicine and […]
Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine Tuesday, March 26 | 12 p.m. ET | Virtual Speaker: Kate Saylor, PhD Fellow, Ethical, Legal, and Social […]
GMKB